NICOLÁS
NAVASA MAYO
Profesor Titular de Universidad
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (7)
2024
-
The Therapeutic Potential of Adipose-Derived Mesenchymal Stem Cell Secretome in Osteoarthritis: A Comprehensive Study
International Journal of Molecular Sciences, Vol. 25, Núm. 20
2021
-
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
Cell Death and Disease, Vol. 12, Núm. 6
2018
-
A multi-omic analysis reveals the regulatory role of CD180 during the response of macrophages to Borrelia burgdorferi article
Emerging Microbes and Infections, Vol. 7, Núm. 1
-
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
Cell Death and Disease, Vol. 9, Núm. 10
2017
-
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
Gastroenterology, Vol. 152, Núm. 6, pp. 1449-1461.e7
-
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
Nature Communications, Vol. 8, Núm. 1
2015
-
Regulation of oxidative stress by methylation-controlled j protein controls macrophage responses to inflammatory insults
Journal of Infectious Diseases, Vol. 211, Núm. 1, pp. 135-145